logo
Book a meeting
Kiora Pharmaceuticals

Kiora Pharmaceuticals

Biotechnology, 271 Waverley Oaks Rd, Encinitas, California, 02452, United States, 11-50 Employees

kiorapharma.com

  • LinkedIn

phone no Phone Number: 78********

Who is KIORA PHARMACEUTICALS

Kiora Pharmaceuticals, Inc. (Kiora) is a clinical development-stage company focusing on novel therapeutics for the treatment of orphan retinal diseases with high unmet need. Publicly trad...

Read More

lock icon Get Full Access
map
  • 271 Waverley Oaks Rd, Encinitas, California, 02452, United States Headquarters: 271 Waverley Oaks Rd, Encinitas, California, 02452, United States
  • 2013 Date Founded: 2013
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834

checked-icon Does something look wrong? Fix it. | View contact records from KIORA PHARMACEUTICALS

Kiora Pharmaceuticals Org Chart and Mapping

Employees
Tara Pleickhardt

Tara Pleickhardt

Controller

Aron Shapiro

Aron Shapiro

Non Executive Director, Board of Directors

See Full Org Chart arrow
email-formate-icon
View Email Formats for Kiora Pharmaceuticals
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding Kiora Pharmaceuticals

Answer: Kiora Pharmaceuticals's headquarters are located at 271 Waverley Oaks Rd, Encinitas, California, 02452, United States

Answer: Kiora Pharmaceuticals's phone number is 78********

Answer: Kiora Pharmaceuticals's official website is https://kiorapharma.com

Answer: Kiora Pharmaceuticals's revenue is $1 Million to $5 Million

Answer: Kiora Pharmaceuticals's SIC: 2834

Answer: Kiora Pharmaceuticals has 11-50 employees

Answer: Kiora Pharmaceuticals is in Biotechnology

Answer: Kiora Pharmaceuticals contact info: Phone number: 78******** Website: https://kiorapharma.com

Answer: Kiora Pharmaceuticals, Inc. (Kiora) is a clinical development-stage company focusing on novel therapeutics for the treatment of orphan retinal diseases with high unmet need. Publicly traded on the NASDAQ under KPRX, our mission is to help patients improve their ocular health and restore vision.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access